• 1
    Gassull MA, Esteve M. Steroid unresponsiveness in inflammatory bowel disease. In: Bayless, TM, Hanauer, SB, eds. Advanced Therapy of Inflammatory Bowel Disease. Hamilton, Canada: BC Decker, 2001: 1337.
  • 2
    Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330: 18415.
  • 3
    Sandborn WJ. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis 1995; 1: 4863.
  • 4
    Wenzl H, Petritsch W, Reicht G, Eherer A, Krejs GJ. Cyclosporin for the treatment of severe ulcerative colitis. Z Gastroenterol 1994; 32: 13740.
  • 5
    Gummert JF, Ikonen T, Morris RE. Newer immunosuppressive drugs: a review. J Am Soc Nephrol 1999; 10: 136680.
  • 6
    Vanrenterghem Y. Tacrolimus (FK 506) in kidney transplantation. Transplant Proc 1998; 30: 21713.
  • 7
    Van Hooff JP, Christiaans MHL. Use of tacrolimus in renal transplantation. Transplant Proc 1999; 31: 32989.
  • 8
    Fellermann K, Tanko Z, Herrlinger KR, et al. Response of refractory colitis to intravenous or oral tacrolimus (FK506). Inflamm Bowel Dis 2002; 8: 31724.
  • 9
    Bousvaros A, Kirschner BS, Werlin SL, et al. Oral tacrolimus treatment of severe colitis in children. J Pediatr 2000; 137: 7949.
  • 10
    Ierardi E, Principi M, Rendina M, et al. Oral tacrolimus (FK 506) in Crohn's disease complicated by fistulae of the perineum. J Clin Gastroenterol 2000; 30: 2002.
  • 11
    Lowry PW, Weaver AL, Tremaine WJ, Sandborn WJ. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae. Inflamm Bowel Dis 1999; 5: 23945.
  • 12
    Marion JF, Rubin PH, Present DH. Differential diagnosis of chronic ulcerative colitis and Crohn's disease. In: Kirsner, JB, ed. Inflammatory Bowel Disease, 5th edn. Philadelphia, PA: W.B. Saunders, 2000, 31525.
  • 13
    Navazo L, Salata H, Morales S, et al. Oral microemulsion cyclosporine in the treatment of steroid-refractory attacks of ulcerative and indeterminate colitis. Scand J Gastroenterol 2001; 36: 6104.
  • 14
    Truelove SC, Witts LJ. Cortisone in the treatment of ulcerative colitis. Final report of a therapeutic trial. Br Med J 1955; 2: 10415.
  • 15
    Stack WA, Long RG, Hawkey CJ. Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis. Aliment Pharmacol Ther 1998; 12: 9738.
  • 16
    Sandborn WJ. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease. Am J Gastroenterol 1997; 92: 8769.
  • 17
    Kornbluth A, Lichtiger S, Present DH, Hanauer S. Long-term results of oral cyclosporin in patients with severe ulcerative colitis: a double-blind, randomized, multi-center trial. Gastroenterology 1994; 106: A714 (Abstract).
  • 18
    Carbonnel F, Boruchowicz A, Duclos B, et al. Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses. Dig Dis Sci 1996; 41: 24716.
  • 19
    Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol 1999; 94: 158792.
    Direct Link:
  • 20
    Rowe FA, Walker JH, Karp LC, Vasiliauskas EA, Plevy SE, Targan SR. Factors predicitve of response to cyclosporin treatment for severe steroid-resistant ulcerative colitis. Am J Gastroenterol 2000; 95: 20008.
    Direct Link:
  • 21
    Wenzl HH, Petritsch W, Aichbichler BW, Hinterleitner TA, Fleischmann G, Krejs GJ. Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis. Z Gastroenterol 1998; 36: 28793.
  • 22
    Domenech E, Garcia-Planella E, Bernal I, et al. Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis. Aliment Pharmacol Ther 2002; 16: 20615.
  • 23
    Actis GC, Aimo G, Priolo G, Moscato D, Rizzetto M, Pagni R. Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial. Inflamm Bowel Dis 1998; 4: 2769.
  • 24
    Van Bodegraven AA, Linskens RK, Van Haelst IM, Sindram JW, Tuynman HA. Addition of low-dose oral cyclosporine in severe ulcerative colitis – pharmacokinetics and clinical outcome report of twelve cases. J Clin Gastroenterol 1998; 27: 723.
  • 25
    Actis GC, Ottobrelli A, Pera A, et al. Continuously infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids. J Clin Gastroenterol 1993; 17: 103.
  • 26
    Santos J, Baudet S, Casellas F, Guarner L, Vilaseca J, Malagelada JR. Efficacy of intravenous cyclosporine for steroid refractory attacks of ulcerative colitis. J Clin Gastroenterol 1995; 20: 2859.
  • 27
    Kornbluth A, Present DH, Lichtiger S, Hanauer S. Cyclosporin for severe ulcerative colitis: a user's guide. Am J Gastroenterol 1997; 92: 14248.
  • 28
    Hanauer SB. Medical therapy for ulcerative colitis. In: Kirsner, JB, ed. Inflammatory Bowel Disease, 5th edn. Philadelphia, PA: W.B. Saunders, 2000, 52956.
  • 29
    Binder V, Brynskov J. Corticosteroids. In: AllanRN, RhodesJM, HanauerSB, et al., eds. Inflammatory bowel disease. 3rd edn. New York: Churchill Livingstone, 1997, 50311.
  • 30
    Travis SP, Farrant C, Ricketts C, et al. Prediciting outcome in severe ulcerative colitis. Gut 1996; 38: 90510.
  • 31
    Dobrolet NC, Webber SA, Blatt J, et al. Hematologic abnormalities in children and young adults receiving tacrolimus-based immunosuppression following cardiothoracic transplantation. Pediatr Transplant 2001; 5: 12531.
  • 32
    Trompeter R, Filler G, Webb NJ, et al. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol 2002; 17: 1419.